Carter Jane Y, Khamadi Samoel, Mwangi Joseph, Muhula Samuel, Munene Stephen M, Kanyara Lucy, Kinyua Joyceline, Lagat Nancy, Chege Judy, Oira Robert, Maiyo Alex, Stewart Roy, Postma Maarten, Stekelenburg Jelle, Osur Joachim, van Hulst Marinus
Regional Laboratory Programme, Amref Health Africa, Nairobi, Kenya
Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya.
BMJ Open. 2025 Apr 2;15(4):e094546. doi: 10.1136/bmjopen-2024-094546.
To assess the prevalence of SARS-CoV-2 antibodies in the residents of Kibera informal settlement in Nairobi, Kenya, before vaccination became widespread, and explore demographic and health-related risk factors for infection.
A cross-sectional study.
Kibera informal settlement, Nairobi, Kenya.
Residents of Kibera informal settlement between October 2019 and August 2021, age 1 year and above who reported no current symptoms of COVID-19.
Associations were determined between SARS-CoV-2 positive tests measured with one rapid test and two ELISAs and demographic and health-related factors, using Pearson's χ test. Crude OR and adjusted OR were calculated to quantify the strength of associations between variables and seropositive status.
A total of 438 participants were recruited. Most (79.2%) were age 18-50 years; females (64.2%) exceeded males. More than one-third (39.1%) were unemployed; only 7.4% were in formal, full-time employment. Less than one-quarter (22.1%) self-reported any underlying health conditions. Nearly two-thirds (64.2%) reported symptoms compatible with COVID-19 in the previous 16 months; only one (0.23%) had been hospitalised with a reported negative COVID-19 test. 370 (84.5%) participants tested positive in any of the three tests. There was no significant difference in SARS-CoV-2 seropositivity across age, sex, presence of underlying health conditions, on medication or those ever tested for SARS-CoV-2. Multiple logistic regression analysis showed that COVID-19 symptoms in the previous 16 months were the only significant independent predictor of seropositivity (p=0.0085).
High SARS-CoV-2 exposure with limited morbidity was found in the residents of Kibera informal settlement. The study confirms other reports of high SARS-CoV-2 exposure with limited morbidity in slum communities. Reasons cited include the high infectious disease burden on the African continent, demographic age structure and underreporting due to limited testing and lack of access to healthcare services; genetic factors may also play a role. These factors require further investigation.
在疫苗广泛接种之前,评估肯尼亚内罗毕基贝拉非正式定居点居民中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗体的流行情况,并探索感染的人口统计学和健康相关风险因素。
一项横断面研究。
肯尼亚内罗毕基贝拉非正式定居点。
2019年10月至2021年8月期间基贝拉非正式定居点的居民,年龄在1岁及以上,且报告目前没有新冠病毒病(COVID-19)症状。
使用一种快速检测和两种酶联免疫吸附测定(ELISA)检测SARS-CoV-2阳性结果,并通过Pearson卡方检验确定其与人口统计学和健康相关因素之间的关联。计算粗比值比(OR)和调整后的OR,以量化变量与血清阳性状态之间关联的强度。
共招募了438名参与者。大多数(79.2%)年龄在18至50岁之间;女性(64.2%)多于男性。超过三分之一(39.1%)的人失业;只有7.4%的人从事正式的全职工作。不到四分之一(22.1%)的人自我报告有任何基础健康状况。近三分之二(64.2%)的人报告在过去16个月中有与COVID-19相符的症状;只有一人(0.23%)曾因报告的COVID-19检测阴性而住院。370名(84.5%)参与者在三项检测中的任何一项中呈阳性。SARS-CoV-2血清阳性率在年龄、性别、是否有基础健康状况、是否正在服药或是否曾接受SARS-CoV-2检测的人群中没有显著差异。多因素logistic回归分析显示,过去16个月中的COVID-19症状是血清阳性的唯一显著独立预测因素(p = 0.0085)。
在基贝拉非正式定居点的居民中发现SARS-CoV-2暴露率高但发病率有限。该研究证实了其他关于贫民窟社区SARS-CoV-2暴露率高但发病率有限的报告。所列举的原因包括非洲大陆的高传染病负担、人口年龄结构以及由于检测有限和缺乏医疗服务而导致的报告不足;遗传因素也可能起作用。这些因素需要进一步调查。